Natural Compounds From Traditional Chinese Medicine Against Doxorubicin‐Induced Cardiotoxicity: Biological Mechanisms and Therapeutic Potential
Basic & Clinical Pharmacology & Toxicology · 2026-05 · 138 (5)
DOI: 10.1111/bcpt.70228 ↗At a glance
Übersichtsarbeit in Basic & Clinical Pharmacology & Toxicology, published online on 2026-03-24. Written by Min Li and 10 co-authors. Institution: Beijing University of Chinese Medicine, Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, China. Major MEDLINE topics: Doxorubicin, Cardiotoxicity, Drugs, Chinese Herbal, Antibiotics, Antineoplastic. Cited 1 times so far (Crossref); 125 references. Funded by: Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China, Leading Talents Project of Beijing New Era of Chinese Medicine 125 Project.
Abstract (original language)
The clinical application of doxorubicin (DOX) is severely restricted by its dose‐dependent cardiotoxicity. This study aimed to investigate the protective mechanisms of traditional Chinese medicine–derived natural compounds (TCM‐NCs) against DOX‐induced cardiotoxicity. A systematic analysis was performed on 104 preclinical studies (encompassing in vivo and in vitro models) retrieved from PubMed, Web of Science and Embase, summarising the cardioprotective effects and mechanisms of 65 TCM‐NCs. These compounds exert multitarget protective effects by modulating six core pathways: oxidative stress/ferroptosis, apoptosis, inflammation/pyroptosis, mitochondrial homeostasis, autophagy and endoplasmic reticulum stress. Target validation further identified Nrf2, Sirt1, mTOR and AMPK as potential central hub nodes underlying their protective actions. These findings offer a theoretical foundation and promising drug candidates for the prevention of chemotherapy‐related cardiac injury, with future research directions focusing on clinical translation and druggability optimisation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Beijing University of Chinese Medicine, Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, China.
- Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
- China Academy of Chinese Medical Sciences, Beijing, China.
- Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
Funding
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- National Natural Science Foundation of China
- Leading Talents Project of Beijing New Era of Chinese Medicine 125 Project
- The Seventh Batch of National Traditional Chinese Medicine Experts Academic Experience Inheritance Project
- The Third Affiliated Hospital of Beijing University of Chinese Medicine Jingcheng Youth Talent Project
- Beijing University of Chinese Medicine Third Affiliated Hospital Natural Cultivation Project
Cite
APA
Li, M., Qiu, R., Wang, S., Xu, Q., Li, K., Chen, H., Zhao, C., Yuan, H., Chen, J., Sun, H., & Shang, H. (2026). Natural Compounds From Traditional Chinese Medicine Against Doxorubicin‐Induced Cardiotoxicity: Biological Mechanisms and Therapeutic Potential. Basic & Clinical Pharmacology & Toxicology, 138(5). https://doi.org/10.1111/bcpt.70228
Vancouver
Li M, Qiu R, Wang S, Xu Q, Li K, Chen H, et al. Natural Compounds From Traditional Chinese Medicine Against Doxorubicin‐Induced Cardiotoxicity: Biological Mechanisms and Therapeutic Potential. Basic & Clinical Pharmacology & Toxicology. 2026;138(5). doi:10.1111/bcpt.70228
BibTeX
@article{Li2026,
author = {Li, Min and Qiu, Ruijin and Wang, Shuai and Xu, Qianqian and Li, Kunze and Chen, Hong and Zhao, Chen and Yuan, Huichan and Chen, Jianquan and Sun, Huiyuan and Shang, Hongcai},
title = {Natural Compounds From Traditional Chinese Medicine Against Doxorubicin‐Induced Cardiotoxicity: Biological Mechanisms and Therapeutic Potential},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2026},
volume = {138},
number = {5},
doi = {10.1111/bcpt.70228}
}
EUVIMED